NLRP3 and autoimmune disease: Simultaneously, the study confirmed that the inhibitor of NLRP3 infalmmasome holds potential as a treatment for related autoinflammatory and autoimmune diseases, thus paving a new path for further exploring the significance of NLRP3 infalmmasome in human health and disease.